Get started
Author

Jessica Mezzanotte-Sharpe

Observed names: J.N. Mezzanotte, Jessica J Mezzanotte, Jessica M. Sharpe, Jessica Mezzanotte, Jessica N. Mezzanotte, Jessica Sharpe, Mezzanotte, Jessica J
Observed institutions: University of Louisville, Vanderbilt University, The Ohio State University Wexner Medical Center, Vanderbilt-Ingram Cancer Center, The Ohio State University, Vanderbilt University Medical Center
ORCID: 0000-0003-2041-5978
Observed ORCID: 0000-0003-2041-5978
OpenAlex ID: A5083066939
Ras signaling through RASSF proteins
2016 · Howard Donninger, M. Lee Schmidt, et al. · Seminars in Cell and Developmental Biology · 106
Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy
2022 · Jessica N. Mezzanotte, Michael Grimm, et al. · Current Treatment Options in Oncology · 80
RASSF6exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells
2014 · Jessica J Mezzanotte, Victoria Hill, et al. · Epigenetics · 46
PDF
Adverse events in patients treated with neoadjuvant chemo/immunotherapy for triple negative breast cancer: results from seven academic medical centers
2025 · Jessica Mezzanotte-Sharpe, Chih-Yuan Hsu, et al. · Breast Cancer Research and Treatment · 11
PDF
An alternative pathway to eusociality: Exploring the molecular and functional basis of fortress defense
2017 · Sarah P. Lawson, Leah T. Sigle, et al. · Evolution · 10
Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial
2024 · Zihan Melink, Maryam B. Lustberg, et al. · Breast Cancer Research and Treatment · 4
PDF
A phase Ib/II trial of atezolizumab with cobimetinib or idasanutlin in metastatic estrogen receptor positive breast cancer
2025 · Jessica Mezzanotte-Sharpe, Brandie C. Taylor, et al. · npj Breast Cancer · 3
PDF
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
2024 · Jessica Mezzanotte-Sharpe, Anne ONeill, et al. · Breast Cancer Research and Treatment · 3
Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case report
2020 · Jessica N. Mezzanotte, I-Sanna Gibbons-Fideler, et al. · Journal of Medical Case Reports · 3
Liquid Biopsies for Cancer
2026 · Jessica Mezzanotte-Sharpe, Katrina Piemonte, et al. · JAMA · 2
PDF
Ras and RASSF Effector Proteins
2016 · J.N. Mezzanotte, G.J. Clark · Elsevier eBooks · 2
Abstract CT072: Novel targeting of the microenvironment to decrease metastatic recurrence of high-risk TNBC: A randomized phase II study of tetrathiomolybdate (TM) plus capecitabine in patients with breast cancer at high risk of recurrence
2026 · Linda T. Vahdat, Nancy Chan, et al. · Cancer Research · 1
Abstract P2-12-14: Adverse events in patients treated with neoadjuvant chemo/immunotherapy for triple negative breast cancer
2025 · Jessica Sharpe, Chih-Yuan Hsu, et al. · Clinical Cancer Research · 1
Abstract P4-09-08: Examining neurocognitive function in breast-cancer patients after chemotherapy
2022 · Jessica Sharpe, Marilly Palettas, et al. · Cancer Research · 1
A research protocol using ECG monitoring for detection of palpitations-associated arrhythmias in breast cancer survivors
2025 · Ying Sheng, Matthew R. Fleming, et al. · PLoS ONE
PDF
Exploratory Analysis of the Impact of a Single Dose of Trastuzumab on the Immune Microenvironment in HER2-Positive Early-Stage Breast Cancer
2025 · Nikita Bastin, Jessica Mezzanotte-Sharpe, et al. · Biomedicines
PDF
Abstract P2-12-29: A randomized clinical trial comparing ctDNA-directed therapy change with standard of care in patients with metastatic triple negative breast cancer (mTNBC)
2025 · Jessica Sharpe, Ben H. Park, et al. · Clinical Cancer Research
Changes in Glucose level During Chemotherapy Treatment in Patients With Stage I–IV Breast Cancer
2025 · Patrick M. Schnell, Mahmoud Kassem, et al. · Clinical Breast Cancer
Phase II double blinded randomized placebo-controlled trial of minocycline to ameliorate chemotherapy-induced cognitive changes in breast cancer (BC) patients.
2021 · Jessica M. Sharpe, Patrick Schnell, et al. · Journal of Clinical Oncology
The discovery of a novel, Ras-mediated NORE1A/PMLIV tumor suppressor complex.
2016 · Jessica Sharpe
PDF
RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells
2014 · Mezzanotte, Jessica J, Hill, Victoria, et al. · Figshare
Characterization of mid-gut proteases in the social aphid, Pemphigus obesinymphae
2009 · Jessica N. Mezzanotte
Works count: 22
Citation count: 273
H-index: 5
I10-index: 5
Year
Topic
Type